Collectively, ours is the first study to evaluate MDK expression and function in SCLC, and the finding that MDK inhibition enhances CDDP efficacy is highly significant as it presents MDK as a potential therapeutic target for SCLC. The gene discussed is MDK; the disease is small cell lung carcinoma.